









Markets
/
Stocks
/
nasdaq-ogi
/

OrganiGram Holdings Inc

OGI

1.880USD

+0.110+6.21%

Close 09/18, 16:00（ET）Quotes delayed by 15 min

251.96MMarket Cap

32.42P/E TTM



OrganiGram Holdings Inc

1.880

+0.110+6.21%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated：2025-09-17

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Despite a very weak market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

56 / 72

Overall Ranking

346 / 4723

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 0 analysts

Current Rating

Target Price

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Organigram Holdings Inc. is focused on producing cannabis for patients and adult-recreational consumers, as well as developing international business partnerships to extend the Company's global footprint. The Company, through its subsidiary, Organigram Inc., is a licensed producer of cannabis, cannabis- derived products and cannabis infused edibles in Canada. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Laurentian, Tremblant Cannabis and Trailblazer. It specializes in vape and infused pre-roll categories backed by a portfolio of owned brands, including the BOXHOT brand. Its products include pre-milled flower, pre-rolls, weed gummies, shred x vapes, and extracts. It operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. Its subsidiaries also include 10870277 Canada Inc.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 208.80.

Overvalued

The company’s latest PE is 134.50, at a high 3-year percentile range.

Institutional Buying

The latest institutional holdings are 51.22M shares, increasing 3.27% quarter-over-quarter.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of -0.15.

Financial Health

Currency: USD Updated：2025-09-17

The company's current financial score is 7.29, which is lower than the Healthcare Providers & Services industry's average of 7.42. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 52.03M, representing a year-over-year increase of 73.30%, while its net profit experienced a year-over-year increase of 324.50%.

Score

Industry at a Glance

Previous score

7.29

Change



Financials

7.02

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

4.66

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

9.22

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

8.22

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.32

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated：2025-09-17

The company’s current valuation score is 4.01, which is higher than the Healthcare Providers & Services industry's average of 2.35. Its current P/E ratio is 134.50, which is -100.36% below the recent high of -0.49 and 102.43% above the recent low of -3.27.

Score

Industry at a Glance

Previous score

4.03

Change

-0.02

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 56/72

No Data

Earnings Forecast

Currency: USD Updated：2025-09-17

There is no earnings forecast score for this company; the Healthcare Providers & Services industry's average is 7.58.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

No Data

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated：2025-09-17

The company’s current price momentum score is 8.28, which is higher than the Healthcare Providers & Services industry's average of 6.88. Sideways: Currently, the stock price is trading between the resistance level at 1.90 and the support level at 1.55, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.77

Change

-0.49

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(1)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.012

Buy

RSI(14)

67.846

Neutral

STOCH(KDJ)(9,3,3)

87.357

Overbought

ATR(14)

0.069

Low Volatility

CCI(14)

160.519

Buy

Williams %R

12.500

Overbought

TRIX(12,20)

0.468

Sell

StochRSI(14)

100.000

Overbought

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

1.712

Buy

MA10

1.674

Buy

MA20

1.654

Buy

MA50

1.542

Buy

MA100

1.423

Buy

MA200

1.374

Buy

Institutional Confidence

Currency: USD Updated：2025-09-17

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

British American Tobacco plc

40.13M

+23.22%

Mario (Naric)

3.07M

Tidal Investments LLC

2.52M

+46.40%

Renaissance Technologies LLC

Star Investors

1.00M

+9.85%

Global X Investments Canada Inc.

868.91K

-0.37%

AdvisorShares Investments, LLC

845.95K

+18.16%

BMO Nesbitt Burns Inc.

309.46K

-32.70%

BN & Partners Deutschland AG

250.00K

Risk Assessment

Currency: USD Updated：2025-09-17

The company’s current risk assessment score is 3.22, which is lower than the Healthcare Providers & Services industry's average of 4.17. The company's beta value is 2.03. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.